Want to see TIL full AI Analyst Report?
Total Valuation
Instil Bio has a market cap or net worth of $50.32M. The enterprise value is $66.37.
Market Cap$50.32M
Enterprise Value$66.37
Share Statistics
Instil Bio has 6,781,976 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,781,976
Owned by Insiders―
Owned by Institutions23.39%
Financial Efficiency
Instil Bio’s return on equity (ROE) is -0.63 and return on invested capital (ROIC) is -26.58%.
Return on Equity (ROE)-0.63
Return on Assets (ROA)-0.35
Return on Invested Capital (ROIC)-26.58%
Return on Capital Employed (ROCE)-0.27
Revenue Per Employee0.00
Profits Per Employee-4.20M
Employee Count17
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Instil Bio is ―. Instil Bio’s PEG ratio is 0.17.
PE Ratio―
PS Ratio0.00
PB Ratio0.64
Price to Fair Value0.64
Price to FCF-2.00
Price to Operating Cash Flow-1.49
PEG Ratio0.17
Income Statement
In the last 12 months, Instil Bio had revenue of 0.00 and earned -71.37M in profits. Earnings per share was -10.70.
Revenue0.00
Gross Profit-534.00K
Operating Income-52.91M
Pretax Income-71.37M
Net Income-71.37M
EBITDA-65.01M
Earnings Per Share (EPS)-10.70
Cash Flow
In the last 12 months, operating cash flow was -33.76M and capital expenditures 0.00, giving a free cash flow of -33.76M billion.
Operating Cash Flow-33.76M
Free Cash Flow-33.76M
Free Cash Flow per Share-4.98
Dividends & Yields
Instil Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta4.89
52-Week Price Change-73.14%
50-Day Moving Average7.87
200-Day Moving Average10.26
Relative Strength Index (RSI)36.68
Average Volume (3m)15.54K
Important Dates
Instil Bio upcoming earnings date is Aug 7, 2026, Before Open (Confirmed).
Last Earnings DateMay 15, 2026
Next Earnings DateAug 7, 2026
Ex-Dividend Date―
Financial Position
Instil Bio as a current ratio of 39.53, with Debt / Equity ratio of 76.95%
Current Ratio39.53
Quick Ratio39.53
Debt to Market Cap1.16
Net Debt to EBITDA-1.21
Interest Coverage Ratio-9.08
Taxes
In the past 12 months, Instil Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Instil Bio EV to EBITDA ratio is -2.34, with an EV/FCF ratio of -4.15.
EV to Sales0.00
EV to EBITDA-2.34
EV to Free Cash Flow-4.15
EV to Operating Cash Flow-4.15
Balance Sheet
Instil Bio has $74.57M in cash and marketable securities with $85.19M in debt, giving a net cash position of -$10.61M billion.
Cash & Marketable Securities$74.57M
Total Debt$85.19M
Net Cash-$10.61M
Net Cash Per Share-$1.57
Tangible Book Value Per Share$17.08
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Instil Bio is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast40.85%